280 related articles for article (PubMed ID: 16858953)
1. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.
Sacco RL; Sivenius J; Diener HC
Arch Neurol; 2005 Mar; 62(3):403-8. PubMed ID: 15767505
[TBL] [Abstract][Full Text] [Related]
4. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
5. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M;
Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
7. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
Weyrich AS; Skalabrin EJ; Kraiss LW
Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
[TBL] [Abstract][Full Text] [Related]
8. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
Rouhl RP; Lodder J
Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet drugs for ischemic stroke prevention.
Leys D; Balucani C; Cordonnier C
Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
11. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Hankey GJ; Eikelboom JW
Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
[TBL] [Abstract][Full Text] [Related]
12. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
Kirshner HS
Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
[TBL] [Abstract][Full Text] [Related]
13. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
14. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
16. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
17. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
Usman MH; Notaro LA; Nagarakanti R; Brahin E; Dessain S; Gracely E; Ezekowitz MD
Am J Cardiol; 2009 Apr; 103(8):1107-12. PubMed ID: 19361598
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI
Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
[TBL] [Abstract][Full Text] [Related]
20. The PRoFESS trial: future impact on secondary stroke prevention.
Diener HC
Expert Rev Neurother; 2007 Sep; 7(9):1085-91. PubMed ID: 17868007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
